Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
Bernard Zinman, Stewart B Harris, Jan Neuman, Hertzel C Gerstein, Ravi R Retnakaran, Janet Raboud, Ying Qi, Anthony JG Hanley. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. The Lancet, Early Online Publication, June 2010, doi:10.1016/S0140- 736(10)60746-5
home
print
ESTATUTOS